Invention Grant
- Patent Title: Therapeutic use of a sterile aqueous ophthalmic solution
-
Application No.: US15769487Application Date: 2016-10-27
-
Publication No.: US10583152B2Publication Date: 2020-03-10
- Inventor: Martin Prinz
- Applicant: Croma-Pharma Gesellschaft M.B.H.
- Applicant Address: AT Leobendorf
- Assignee: CROMA-PHARMA GESELLSCHAFT M.B.H.
- Current Assignee: CROMA-PHARMA GESELLSCHAFT M.B.H.
- Current Assignee Address: AT Leobendorf
- Agency: Workman Nydegger
- Priority: EP15192362 20151030
- International Application: PCT/EP2016/075939 WO 20161027
- International Announcement: WO2017/072236 WO 20170504
- Main IPC: A61K31/722
- IPC: A61K31/722 ; A61K47/02 ; A61K47/12 ; A61K9/00 ; A61K9/08 ; A61P27/02
Abstract:
The present invention relates to a sterile aqueous ophthalmic solution comprising N—(N-acetylcysteinyl-)chitosan or a pharmaceutically acceptable salt thereof in a carrier solution, wherein the N—(N-acetylcysteinyl-)chitosan has a content of free thiol groups in an amount of from 80 μmol/g polymer to 280 μmol/g polymer, for use in the treatment of corneal wounds.
Public/Granted literature
- US20180303865A1 Therapeutic Use of a Sterile Aqueous Ophthalmic Solution Public/Granted day:2018-10-25
Information query
IPC分类:
